株探米国株
英語
エドガーで原本を確認する
6-K 1 rdy0745_6k.htm FORM 6-K
 


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

May, 2025

Commission File Number 1-15182

 

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)


8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                                        Form 40-F   ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

 

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

 

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes  ¨                                        No   x

 

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.


 

 

EXHIBITS

 

Exhibit

Number

  

Description of Exhibits

 

 

 

99.1


Intimation dated May 9, 2025

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

DR. REDDY’S LABORATORIES LIMITED

(Registrant)

 

 

 

 

Date: May 9, 2025

By:

/s/ K Randhir Singh

 

 

Name:

K Randhir Singh

 

 

Title:

Company Secretary

 

3
EX-99.1 2 rdy0745_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

Dr. Reddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills

Hyderabad – 500 034, Telangana, India

CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900

Fax: + 91 40 4900 2999

Email: mail@drreddys.com

Web: www.drreddys.com

 

May 9, 2025

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Ltd. (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 

This is to inform that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company at its meeting held on May 8 & 9, 2025, has approved the grant of stock options to the eligible employees under the Employees Stock Option Schemes of the Company:


Sl.

No.

Type of

Option(s)

Number

of options

granted

 Value

Exercise

Price per

share

ESOP Scheme

1

Indian Stock Options

 

 

 9,15,763

 

Fair Market Value

 Rs. 1,162/-

Dr. Reddy’s Employees Stock Option Scheme, 2018

2

American Depository

Receipts (ADRs) Stock Options

    3,53,057

Fair Market Value

Rs. 1,162/-

Dr.  Reddy's Employees

ADR Stock Option

Scheme, 2007

 

 

This is for your information and records.

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited (Pursuant to SEBI Master Circular No SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024)

K. Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

 

 



BRIEF DETAILS ON THE GRANT OF STOCK OPTIONS

 

S.No

Particulars

Details

1.

Brief details of options granted

Grant of 9,15,763 under Dr. Reddy’s Employees Stock Option Scheme, 2018, to the eligible employees of the company.

Grant of 3,53,057 stock options under Dr.  Reddy's Employees ADR Stock Option Scheme, 2007 to the eligible employees of the company.

2.

Whether the scheme is in terms of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (if applicable)

Yes

Yes

3.

Total number of shares covered by these options

9,15,763

3,53,057

4.

Pricing formula/ Exercise Price / Grant Price

Rs.1,162 per stock option

Rs.1,162 per stock option

5.

Options vested / vesting schedule

100% vesting at the end of 3 years

 

100% vesting at the end of 3 years

6.

Time within which option may be exercised

According to respective vesting schedule

According to respective vesting schedule

7.

Brief details of significant terms

Stock options granted are governed under the Dr. Reddy’s Employees Stock Option Scheme, 2018, which is administered and implemented by the Nomination, Governance & Compensation Committee

Stock options granted are governed under the Dr.  Reddy's Employees

ADR Stock Option Scheme, 2007, which

is administered and implemented by the Nomination, Governance & Compensation Committee

8.

Options exercised

Not Applicable

Not Applicable

9.

Money realized by exercise of options

10.

The total number of shares

arising as a result of exercise of option

11.

Options lapsed

12.

Variation of terms of options

13.

Subsequent changes or

cancellation or exercise of such options

14.

Diluted earnings per share

pursuant to issue of equity

shares on exercise of options